Squawk on the Street

CNBC’s “Squawk on the Street” team discusses the news that Pfizer’s Covid vaccine appears to be 100% effective in 12-

There’s new optimism surrounding Pfizer’s coronavirus vaccine’s ability to fight against the rapidly spreading new variants. CNBC’s Meg Tirrell reports.

The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the

Dr. Lloyd Minor, dean of Stanford Medicine, joins “Squawk on the Street” to discuss the push for a coronavirus vaccine.

CNBC’s Meg Tirrell joins “Squawk on the Street” to break down final guidelines on who will get the coronavirus vaccine

Moncef Slaoui, White House chief advisor of Operation Warp Speed, joins “Squawk on the Street” to discuss developments in a

CNBC’s Meg Tirrell details the latest in the effort to develop a coronavirus vaccine as Moderna releases interim phase one

CNBC’s Meg Tirrell delivers the latest on Moderna’s trial of a coronavirus vaccine. Moderna’s closely watched early-stage human trial for

Daniel Menichella, CEO of CureVac, joins “Squawk on the Street” to discuss how the company could get a vaccine for